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Abstract: Guided bone regeneration (GBR) evolved from the concept of guided tissue
regeneration (GTR) and has been used for reconstructing sites with bone deficiencies associated
with dental implants. For GBR, the use of absorbable collagen membranes has been
increasing, but, at present, scientific information on the use of collagen membranes for
GBR is limited. This study was aimed to clinically and histomorphometrically compare two
collagen membranes, Bio-GideA and BioMend ExtendTM, for the treatment of implant
dehiscence defects in eight mongrel dogs. Implant dehiscence defects were surgically created
in edentulous ridges, followed by the placement of three endosseous implants bilaterally in the
mandible. Each implant dehiscence defect was randomly assigned to one of three treatment
groups: (1) control (no membrane), (2) porcine dermis collagen barrier (Bio-Gide) or (3)
bovine tendon collagen barrier (BioMend Extend). Dogs were sacrificed at 4 and 16 weeks
(four dogs each) after treatment. Histomorphometric analysis included percentage linear
bone fill (LF), new bone-to-implant contact (BIC) and area of new bone fill (BF). The results
of the study revealed no significant differences among groups for any parameter at 4
weeks. However, at 16 weeks, more LF, BIC, and BF were noted in the membrane-treated
groups than controls. BioMend Extend-treated defects demonstrated significantly greater BIC
than control (P  0.05) at this time point. BIC at 16 weeks was significantly greater than 4-
week BIC (P  0.05). Membrane exposure occurred in 9 out of 15 sites examined, resulting in
significantly less LF and BIC than the sites without membrane exposure (P  0.05). The results
of this study indicate that: (1) GBR treatment with collagen membranes may significantly
enhance bone regeneration, manifested at late stage (16 weeks) of healing; and (2) space
maintenance and membrane coverage were the two most important factors affecting GBR
using bioabsorbable collagen membranes.
The demand for replacing missing teeth
with dental implants has increased dra-
matically; however, it has often been
limited by the amount of available bone.
Guided bone regeneration (GBR) was intro-
duced to correct this deficiency and has
shown promising results. The concept of
GBR evolved from guided tissue regenera-
tion (GTR) and is used to compartmental-
ize neosteogenesis using barrier mem-
branes by protecting the blood clot, cre-
ating space, and excluding soft tissue cell
proliferation (Boyne 1969; Dahlin et al.
1988; Dahlin et al. 1991; Linde et al.
1993a).
Fugazzotto et al. (1997) assessed 1503
GBR-treated implant sites with clinical re-
entries and reported an overall success rate
of 97.0% for the treatment of dehisced or
fenestrated implants placed in immediate
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extraction sockets. Hermann & Buser
(1996) discussed five surgical factors that
are required to achieve predictable results
with GBR procedures:
1 use of an appropriate membrane;
2 achievement of primary soft tissue
healing;
3 creation and maintenance of a mem-
brane-protected space;
4 close adaptation and stabilization of the
membrane to the surrounding bone;
5 sufficiently long healing period.
While GTR procedures are associated with
natural teeth, GBR is mainly involved in
implant dentistry where inadequate bone
is the concern. Adequate bone volume is
one of the requirements for the successful
installation and osseointegration of an en-
dosseous implant (Lekholm & Zarb 1985).
GBR is often used in extraction sockets,
deficient ridges, and dehiscence and fen-
estration defects, associated with dental
implants (Mellonig & Nevins 1995).
Prerequisites for an ideal barrier mem-
brane include biocompatibility, cell occlu-
sivity, tissue integration, space-making ef-
fect, and clinical manageability. The e-
PTFE membrane, nonabsorbable, appears
to fulfill these needs. However, it has been
recognized that the use of the nonab-
sorbable membrane has been limited by
the necessity of second surgery for mem-
brane removal and its high membrane ex-
posure rate (Gotfredsen et al. 1993; Becker
et al. 1994; Simion et al. 1994a), poten-
tially resulting in patient discomfort, in-
creased cost, postsurgical infection, and
possibly suboptimal bone regeneration. Bi-
oabsorbable membranes were then de-
veloped and have demonstrated compar-
able results to the e-PTFE membrane in
numerous experimental animal studies
(Sandberg et al. 1993; Sevor et al. 1993;
Zellin et al. 1995) and case reports (Balshi
et al. 1991; Sevor & Meffert 1992; Lundgr-
en et al. 1994; Mayfield et al. 1997). Cur-
rently tested and used absorbable mem-
branes are made of collagen or of poly-
glycolic acid, polylactic acid, or
copolymers (Hutmacher et al. 1996;
Wang & MacNeil 1998).
Collagen membranes are mechanically
malleable, adaptable, and easy to manipu-
late, which may be beneficial in clinical ap-
plication. Other advantageous properties of
collagen include hemostatic function, facil-
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itating early wound stabilization, semiper-
meability, allowing nutrient passage, natu-
ral enzymatic degradation, and chemotactic
ability to attract fibroblasts (Postlethwaite
et al. 1978). The safety and efficacy of colla-
gen membranes have been proven in the
field of GTR (Blumenthal 1988; Wang et al.
1994; Crigger et al. 1996; Yukna & Yukna
1996) as well as in GBR (Sevor et al. 1993;
Zitzmann et al. 1997; Hürzeler et al. 1998).
Hürzeler et al. (1998) evaluated a bioabsorb-
able membrane, Bio-GideA (Osteohealth,
Shirley, NY, USA), used for GBR around ex-
posed implant threads in monkeys, and
showed histologically comparable effects of
the membrane to the e-PTFE membrane
when used with Bio-OssA (Osteohealth,
Shirley, NY, USA) bone graft materials.
Buccal dehiscence defects are one of the
most commonly encountered problems in
implant dentistry. There have been a num-
ber of experimental and clinical studies on
GBR using this type of defect (Zablotsky
et al. 1991; Becker et al. 1992; Sevor et al.
1993; Zitzmann et al. 1997; Hämmerle
et al. 1998; Peleg et al. 1999). Compared to
the lingual bone, especially in the maxil-
lary anterior region, buccal bony housing is
thin; thus, bone resorption after tooth ex-
traction in buccal areas is faster and far
more prevalent. According to Lam (1960),
the abundant bone volume does not re-
main more than a few years following
tooth loss, and the original crestal width is
reduced by at least 30% within 2years
after extraction. To overcome the difficulty
of space creation around buccal dehiscence
defects, several treatment approaches, such
as membranes with space fillers or ti-
tanium-reinforced e-PTFE membranes, are
often utilized in GBR (Simion et al. 1994b;
Fritz et al. 2000)
Longevity and space-maintaining ability
are the most challenging concerns regard-
ing absorbable membranes in GBR pro-
cedures. Studies have demonstrated that
early removal of membranes resulted in re-
duced bone formation and incomplete
bone fill (Lekholm et al. 1993; Becker et al.
1994). Several clinicians have advocated
that membranes used for GBR should last
longer, ranging 3–9months, than GTR
membranes. Bio-Gide, a collagen mem-
brane claimed to last 4–6months, was de-
veloped to fulfill this goal. Several other
companies have also developed other long-
lasting membranes, including BioMend Ex-
tendTM (Sulzer Calcitek, Carlsbad, CA,
USA) and Ossix TM (Implant Innovations,
Inc., Palm Beach Gardens, FL, USA).
Bio-Gide is derived from porcine dermis
and composed of type I and III collagen. It
has two layers: (1) the compact layer, de-
signed to protect soft tissue invasion; and
(2) the porous layer, designed to facilitate
integration of newly formed bone. Bi-
oMend Extend is a type 1 collagen mem-
brane derived from bovine tendon and is
highly cross-linked to prolong membrane
barrier function to maximize time necess-
ary for tissue regeneration.
There have been limited histomorpho-
metric studies specifically on GBR using
collagen membranes. The present study
was aimed to compare, clinically and histo-
morphometrically, the effects of two differ-
ent collagen membranes (BioGide and Bi-
oMend Extend) on GBR in surgically
created buccal implant dehiscence defects
in dogs.
Material and methods
Eight systemically healthy male mongrel
dogs, aged from 1 to 2years and weighing
24–43kg, were used in this study. The dogs
had full, well-aligned dentitions without
clinical signs of destructive periodontal dis-
ease. The study was performed following
approval by the University Committee on
Use and Care of Animals (UCUCA) at the
University of Michigan.
Surgical management
After an adaptation period of 4weeks, each
animal received full-mouth scaling and ex-
traction of the mandibular 2nd, 3rd, and
4th premolars (P2–P4) bilaterally under
general anesthesia. After 16weeks of heal-
ing, buccal dehiscence defects were pre-
pared as described by Becker et al. (1992).
Midcrestal incisions followed by full thick-
ness mucoperiosteal flap elevation were
performed, and the crestal bone was uni-
formly prepared by osteoplasty using a
round bur or bone chisel. Following im-
plant site preparation (surgery protocol by
Sulzer Calcitek), buccal dehiscence defects,
approximately 4mm in height from the
crestal bone, 3mm in depth from the sur-
face of the buccal bone, and 3mm in width
mesiodistally, were created with a straight
fissure carbide bur. The osteotomy pro-
cedures were carried out under copious sa-
line irrigation. The defect size was stan-
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dardized with the use of a periodontal
probe. After defect creation, three titanium
threaded implants (SplineTM TWIST
MTXTM, Sulzer Calcitek, Carlsbad, CA,
USA), 3.75mm in diameter and 8mm in
length, were placed in each quadrant, and
three treatment modalities (Bio-Gide, Bi-
oMend Extend or control) were randomly
assigned to each implant defect using a
random number table (Fig.1). Block ran-
domization was used for grouping with
each quadrant as a block. The membranes
were trimmed and placed over the defects
to cover the implant and defect, extending
2–3mm beyond the defect margin. Primary
wound closure was accomplished by flap
releasing and closure with 4-0 Vicryl (poly-
glactin 910) suture using the simple inter-
rupted suture technique to achieve pri-
mary intention healing.
Oral hygiene and diet
During the presurgical period, animals re-
ceived three times weekly toothbrushing
with a soft brush and 0.2% chlorhexidine
gel. Following surgery, chlorhexidine swab-
bing of tissues was performed in lieu of
Fig.1. Defect creation, implant insertion, and membrane placement. a. Implant placement in a standardized
defect (3¿4¿5mm). Three titanium threaded implants (3.75mm¿8mm) were placed. b. Random assignment
of three treatment groups (from left to right: BioMend ExtendTM, Control and Bio-GideA).
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brushing for 2weeks. The dogs were fed a
daily canine diet (LabDiet Certified Canine
Diet 5007, PMI Feeds, Inc., ) and filtered
tap water ad libitum. For the first 3weeks
after surgery, a soft diet was used to mini-
mize mechanical trauma to the flaps.
Bone labeling
To assess the pattern of osteogenesis and
delineate the base of the original defect,
three fluorochrome bone labels were used.
For the 4-week biopsy group, a series of
three bone labels were administrated in the
following sequence (Giannobile et al.
1998):
O calcein green (8mg/kg, IM) 2days after
implant placement;
O xylenol orange (60mg/kg, IV) 2weeks
after the surgery;
O tetracycline HCl (10mg/kg, I.M.) 2days
prior to sacrifice.
For 16-week biopsy specimens, animals re-
ceived a series of four bone labels:
O calcein green (8mg/kg, IM) 2days after
implant placement;
O xylenol orange (60mg/kg, IV) 8weeks
after surgery;
O tetracycline HCl (10mg/kg, IM) 12
weeks after surgery;
O alizarin red (25mg/kg, IM) 2days prior to
sacrifice.
Therefore, these labels were administered
to determine the rate and extent of osteo-
genesis at 2, 4, 8, 12, and 16weeks post-
surgery.
Clinical reentry and histological procedure
Animal sacrifice was carried out after
4weeks (nΩ4 dogs) and after 16weeks (nΩ
4 dogs) with an overdose of pentobarbital
(65mg/kg, IV, to effect). At animal sacri-
fice, clinical reentry was performed on one
quadrant at each time point to accrue clin-
ical information and supplement histology
data. Block biopsies of each quadrant in-
cluding three implants and surrounding
tissues were obtained, fixed in 10% neutral
buffered formalin for 4–7days and then
stored in 70% ethanol solution individu-
ally. These specimens were then dehy-
drated using ascending grades of alcohol,
infiltrated, and embedded in methyl meth-
acrylate (MMA) for nondecalcified sec-
tioning (Sanderson & Kitabayashi 1994).
The orientation of the sections was trans-
verse along the length of the implant
which presented a view of the buccal de-
fects. Three serial sections, 500mm in
thickness, were taken along the long axis
of the implant at the central portion of the
fixture using a diamond wire saw (Well
Diamond Wire Saws, Inc., Norcross, GA,
USA). Each section was glued to a plastic
slide (Wasatch Histo Consultants, Inc.,
Winnemucca, NV, USA) (Bloebaum et al.
1989), ground to approximately 50–70mm
utilizing an EXAKT Micro Grinder 400
(Exakt Medical Instruments Inc., Oklaho-
ma City, OK, USA), and polished to an op-
tical finish. One section per each implant
site was left unstained for fluorescence
analysis, and the two remaining sections
were stained with Sanderson’s Rapid Bone
StainTM (Surgipath Medical Industries,
Richmond, IL, USA) and an acid fuchsin
counterstain. Histomorphometric analyses
as well as microscopic observation were
performed by a calibrated, blinded exam-
iner. For histomorphometric measure-
ments, microscopic images were trans-
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Fig.2. Histomorphometric references (original magni-
fication: 20¿, Sanderson’s Rapid Bone StainTM). 1–
Defect Length: AC. 2ª% Linear Fill (LF): BC/AC
(¿?100). 3– New BIC (BIC): Sum of BIC/Total length
of threads (D) (¿100). 4ªNew Bone Fill Area (BF):
Area of new bone formation. A: reference point, B:
coronal extent of new bone, C: base of the defect, D:
total defect length.
ferred to an IBM computer and analyzed
with an image analysis software (Image-Pro
PlusA, The Imaging ExpressTM, Media Cy-
bernetics Inc., Silver Spring, MD, USA).
Histomorphometry
Parameters evaluated included:
O defect length (measured from the top of
the implant neck to the base of the de-
fect);
O percent linear fill (LF: new bone height
divided by original defect length);
O percent new bone-implant contact (BIC);
O area of new bone fill (BF) (Fig.2).
Descriptive histologic findings were also
noted, such as pattern of osteogenesis, cell
distributions, membrane remnants, mem-
brane collapse, and fiber content.
Statistical analysis
For the assessment of the various treat-
ment outcomes, two-tailed Student t-test
was used for the mean differences within
each group between 4 and 16weeks, and
pairwise one-way ANOVA was used for
overall mean differences between groups at
each time point. For the comparison in the
treatment outcomes between membrane
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exposure and nonexposure groups, two-
tailed Student t-test was utilized. For all
statistics, the significance level used was
P0.05, and the data were presented as
mean∫standard error.
Results
The animals demonstrated clinical signs of
healing within normal limits with no signs
of infection or wound dehiscence. One im-
plant in the 16-week group (BioMend Ex-
tend site) was lost during the healing
period. Clinical reentry revealed no thread
exposure in any reentered site, but the
superficial layer of the defect fill resembled
granulation tissue in appearance and tex-
ture. For histomorphometric analyses, the
implant sites for clinical reentry were left
intact, without removal of the granulation
tissue. Membrane exposure was noted in
nine out of 15 membrane-placed implant
sites, five Bio-Gide and four BioMend Ex-
tend, at 16weeks (one failed implant site
was excluded). The exposure, when pres-
ent, generally occurred with both mem-
brane sites of the quadrant in a similar pat-
tern.
Histologic observation
Histologically, four implants (one Bio-Gide
at 16weeks and three controls, one at
4weeks and two at 16weeks) failed to
demonstrate osseointegration, revealing
fibrous encapsulation of the fixture. Ad-
ditionally, one implant site in 4-week Bi-
oMend Extend group did not provide dis-
cernible sections and was excluded for his-
tological evaluation. Therefore, the
histologic and histometric analyses were
carried out on a total of 42 specimens, 21
specimens for each time period.
In all groups, 4-week specimens demon-
strated woven bone formation, character-
ized by abundant trabecular pattern and
bone marrow spaces, and the level of BIC
was generally very low (Fig.3). All mem-
brane-treated sites demonstrated space
maintenance underneath barrier mem-
branes. Under higher magnification, the re-
generated bone presented high levels of tra-
becular pattern, lined with osteoid seams
and numerous osteoblast-like cells, and the
bone trabeculae were in close contact with
blood vessels, revealing active angiogenesis
and osteogenesis in this early healing
phase.
In contrast to the 4-week observation,
more organized, dense, and mature bone
was generally noted for the 16-week speci-
mens, suggesting lamellar bone formation,
and intimate contacts between the bone
and implant were frequently observed
(Fig.4). There were signs of membrane dis-
integration, with membrane remnants vis-
ible in all membrane sites. Higher magni-
fication demonstrated the presence of nu-
merous osteoblasts, especially outside the
border of the defect and near implant
threads, suggesting continuous deposition
of lamellar bone into a previously outlined
bone envelope. Membrane collapse was
histologically revealed in nine sites, eight
membrane-exposed sites (five Bio-Gide and
three BioMend Extend sites) and one non-
exposed site (Bio-Gide).
At 4weeks, newly formed bone was
clearly demarcated with previously present
lamellar bone by different levels of stain,
while the junction between new and old
bone was not clearly differentiable at
16weeks. Fluorochrome labeling (calcein
green) was used to histologically ensure or
identify the junction between the old and
newly formed bone (Fig.5). In addition,
fluorescence findings revealed that the pat-
tern of osteogenesis until 4weeks appeared
as a volumetric increase of osseous tissues
into defect areas, whereas there were signs
of density increase in a previously occupied
area in 16-week specimens.
Histomorphometric analysis
Calibration of intra- and interexaminer
errors in histometric measurements re-
sulted in 99.3% intraexaminer (TO) and
96.9% interexaminer agreement with the
reference examiner (W.G.). Table1 lists his-
tometric comparison between time (4 and
16weeks) and treatment groups. There
were no statistically significant differences
between groups in baseline defects, range
3.08–3.41mm, at either time point (4 and
16weeks). At 4weeks, no statistically sig-
nificant differences were noted in any of
the assessed parameters. The mean LF was
in the range of 65–70%. The mean BIC
ranged from 11% to 19% among groups,
and BF ranged from 1.12mm2 to 1.46mm2.
At 16weeks, there was a trend for
greater improvements in membrane groups
when compared to the control group for all
parameters. There was statistically sig-
nificantly more new BIC found in Bi-
oMend Extend compared to the control at
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Fig.3. Histologic observation at 4weeks: In general, trabeculae of woven bone with abundant bone marrow spaces and low degree of BIC were observed. The newly
formed bone was clearly demarcated by old bone, as demonstrated by lighter bone stain in new bone and darker stain in old bone (original magnification: 20¿,
Sanderson’s Rapid Bone StainTM). aªBio-GideA (nΩ7): Trabeculae-rich woven bone formation. Soft tissues were missing due to clinical re-entry. Note the low degree
of new BIC. bªThe BioMend ExtendTM collagen membranes and implants used in the study were donated by Sulzer Calcitek Dental Inc. BioMend ExtendTM (nΩ7):
The membrane (arrows) remained intact and maintained a space for bone regeneration. cªControl (nΩ7): Similar to the membrane sites, a trabecular pattern of woven
bone formation is shown.
this time point (P0.05). Although there
were no statistically significant differences
between membrane groups and control
group in LF and BF, membrane groups had
approximately 60% of LF and 1.3–1.9mm2
BF, in contrast to 45% of mean LF and
0.9mm2 BF in the control group.
Treatment outcomes between sites with
membrane exposure and sites without ex-
posure were also evaluated (Table2). Over-
all, the sites with membrane exposure
demonstrated significantly less mean LF
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(50.9% vs. 69.8%) and less new BIC (31.0%
vs. 52.3%) (P0.05). Although the mean
BF in sites without membrane exposure
was nearly twice as compared to exposed
sites (1.12mm2 vs. 2.05mm2), the differ-
ence did not reach statistical significance.
Membrane exposure negatively influenced
all the parameters in Bio-Gide group
(P0.05); on the other hand, only new BIC
was significantly influenced by membrane
exposure in BioMend Extend group
(P0.05). In general, membrane exposure
was followed by membrane collapse (loss
of space maintaining effect), resulting in
significantly less bone regeneration.
Discussion
Utilizing two different collagen mem-
branes to enhance bone augmentation in
implant dehiscence defects were clinically
and histologically evaluated in this canine
study. Histologic analysis can be con-
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Fig.4. Histologic observation at 16weeks: Mature, well-organized lamellar bone had been deposited in the defects. Compared to 4weeks, new BIC levels at 16weeks
were significantly higher. Membrane groups demonstrated significantly greater linear bone fill and new bone area than control group (original magnification: 20¿ and
100¿, Sanderson’s Rapid Bone StainTM). aªBio-GideA (nΩ8): The newly formed bone was not readily distinguishable from old bone at the junction (j). The membrane
(arrow) was mixed with collagen-rich fibers (asterisk), beginning to disintegrate. bªBioMend ExtendTM (nΩ7): A space had been maintained with a barrier membrane.
Evidence of new bone formation and new BIC can be noted. cªControl (nΩ6): There was little evidence of space maintenance in this control specimen. dªHigher
magnification: Membrane remnants (arrow) and numerous osteoblasts were observed especially outside border of the defect. Note the intimate contact between the
implant threads and newly formed bone.
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Fig.5. Fluorescence. aª4weeks: Fluorochrome label-
ing showed a timely manner of new bone formation.
The junction between new bone and preexisting
bone was characterized by heavy labeling with calc-
ein green. Moreover, active bone regeneration was in-
dicated by xylenol orange staining, which revealed a
trabecular pattern, starting from the margin of old
bone and underneath BioMend ExtendTM membrane
(arrows) (original magnification: 20¿, fluorescence).
bª16weeks: Calcein green fluorochrome (asterisks)
delineated the position of the junction between re-
generated bone and old bone. Unlike 4-week fluor-
escence, this 16-week specimen showed a ring-type
pattern of bone formation, indicating the presence
of abundant osteons (arrows) (original magnification:
20¿, fluorescence).
sidered the gold standard for evaluation of
bone regeneration. Due to the difficulty in
obtaining histologic materials from
humans, animal studies possess the advan-
tage of attaining on standardized lesions for
GBR (Dahlin et al. 1988; Dahlin et al.
1990; Hämmerle et al. 1992; Linde et al.
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Table 1. Histometric comparison between collagen barriers on bone healing at 4 and 16weeks
Defect Linear fill New BIC Bone fill
(mm) (%) (%) (mm2)
BioGideA(n Ω 8)
4 weeks 3.08 ∫ 0.10 65.35 ∫ 9.15 16.80 ∫ 2.62 1.46 ∫ 0.26
16 weeks 3.29 ∫ 0.12 57.88 ∫ 6.84 34.82 ∫ 4.77* 1.29 ∫ 0.32
BioMend ExtendTM (n Ω 7)
4 weeks 3.28 ∫ 0.11 67.59 ∫ 8.79 11.35 ∫ 5.10 1.27 ∫ 0.12
16 weeks 3.11 ∫ 0.11 59.17 ∫ 5.36 44.83 ∫ 4.86*† 1.73 ∫ 0.39
Control (n Ω 6)
4 weeks 3.41 ∫ 0.12 69.45 ∫ 7.92* 19.15 ∫ 2.96 1.12 ∫ 0.14
16 weeks 3.09 ∫ 0.15 44.82 ∫ 5.01 27.76 ∫ 2.38* 0.88 ∫ 0.19
*Statistically significant difference between 4 and 16 weeks (P  0.05).
†Statistically significant difference between treatment groups at 4 and 16 weeks (P  0.05).
Data were presented as mean ∫??num? standard error.
1993b; Sandberg et al. 1993; Schenk et al.
1994; Zellin et al. 1995).
The histomorphometric analysis in this
study demonstrated that the placement of
collagen membranes enhanced bone re-
generation as determined at 16weeks of
healing, including regeneration of bone
height and volume as well as bone-to-im-
plant contact. Becker et al. (1992) studied
GBR in implant dehiscence defects in dogs.
Clinical reentry data at 18weeks of the
study revealed that the e-PTFE membrane
alone group gained approximately 90% of
LF, higher than the average LF of the mem-
brane groups in the present study. Histo-
metric analysis at 18weeks in the study by
Becker et al. (1992) demonstrated that new
BIC was 23% for the e-PTFE alone group
and 41% for e-PTFE plus growth factors
group; on the other hand, the new BIC of
BioMend Extend group in this study was
almost 45%. The differences between the
two studies in LF and new BIC are likely
attributed to several factors. In the Becker
et al. (1992) study, the implant dehiscence
defects were created around immediate ex-
traction sockets that were longer (i.e. 5mm
in height). In addition, the methods of
evaluating the defect resolution were dif-
ferent: Becker et al. (1992) used clinical
measurements at reentry to assess LF
whereas histometric analysis was used in
the current study. It can be speculated that
there would be a difference between clin-
ical and histometric measurements in as-
sessing degree of healing after GBR. Schlie-
phake et al. (2000) histometrically analyzed
linear bone fill (LF), comparing a polylactic
acid (PLA) absorbable membrane and e-
PTFE membrane used for GBR around sur-
gically created circumferential implant de-
fects in dogs. The study reported that the
average LF at 3months reached approxi-
mately 45% in e-PTFE group and 40% in
PLA group, lower than the present study
and considerably less than Becker et al.
(1992)ƒs clinical data. Moreover, in the cur-
rent study, clinical observation at re-entry
showed no thread exposure, which was dif-
ferent from the histometric data showing
approximately 60% of LF at 16weeks.
However, due to the limited sites of clin-
ical re-entry, it was not possible to statisti-
cally compare the two measures of analy-
sis. Third, the different types of implant
surfaces used in the two studies should be
considered. Machined titanium implants
were used in Becker et al. (1992), while
microtextured (grit-blasted) implants were
placed in the present study. It has been
demonstrated that the level of new BIC is
significantly influenced by implant surface
roughness, being greater BIC in surface-
roughened implants compared to ma-
chined titanium surfaces (Buser et al. 1991;
Stentz et al. 1997; Buser et al. 1998; Wen-
nerberg et al. 1998; Cochran 1999). Other
factors for the different outcomes between
the two studies may include use of differ-
ent types of membrane barriers.
Histometric comparison between 4 and
16weeks demonstrated that there was sig-
nificant increase in BIC (P0.05) at
16weeks. This finding may be explained
by progressing contact osseointegration, as-
sociated with bone maturation. Interest-
ingly, there were no significant differences
between early and late healing in LF and
BF, except for a significantly lower LF at
16weeks than 4weeks in control group
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Fig.6. Histologic appearance of membrane exposure
vs. no membrane exposure at implant dehiscence de-
fects at 16weeks (original magnification: 20¿,
Sanderson’s Rapid Bone StainTM). aªSite with mem-
brane exposure (nΩ9): The soft tissue and membrane
were collapsed, resulting in less bone regeneration.
bªSite without membrane exposure (nΩ6): The
structural integrity of the barrier membrane re-
mained undisturbed, with space maintenance for
new bone formation
(P0.05). This is mainly attributed to sev-
eral inherent problems of the current
study. The small sample size in association
with biologic variability, manifested by
considerably high standard deviation,
might have influenced the lack of statisti-
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Table 2. Influence of membrane exposure on bone regeneration 16weeks postsurgery
Defect Linear fill New BIC Bone fill
(mm) (%) (%) (mm2)
Exposure (n Ω 9) 3.27 ∫ 0.12 50.92 ∫ 5.01 30.95 ∫ 0.03 1.12 ∫ 0.26
No exposure (n Ω 6) 3.11 ∫ 0.11 69.82 ∫ 4.95* 52.31 ∫ 0.03* 2.05 ∫ 0.40
BioGideA
Exposure (n Ω 5) 3.39 ∫ 0.24 47.23 ∫ 9.54 27.20 ∫ 7.31 0.80 ∫ 0.55
No exposure (n Ω 3) 3.11 ∫ 0.27 75.63 ∫ 9.93* 47.52 ∫ 3.31* 2.10 ∫ 0.46*
BioMend ExtendTM
Exposure (n Ω 4) 3.12 ∫ 0.29 55.54 ∫ 13.43 35.63 ∫ 2.39 1.53 ∫ 0.65
No exposure (n Ω 3) 3.10 ∫ 0.14 64.01 ∫ 7.32 57.10 ∫ 6.69* 2.01 ∫ 1.06
*Statistically significant difference between exposure and no exposure (P  0.05).
Data were presented as mean ∫??num? standard error.
cal significance. In addition, membrane (or
space) collapse and flap exposure might
also have negatively influenced the out-
come of the late stage of bone healing, re-
sulting in less LF at 16weeks compared to
at 4weeks. However, under the limit of the
findings of this study, it is implied that as
bone matures from early phase to late stage
of healing, BIC and density increase, with-
out significant increases in bone height or
bone fill. There could be a question raised
as to whether or not the pattern of bone
maturation involves bone volume reduc-
tion accompanied by density increase.
Significant differences in treatment out-
comes between sites with membrane ex-
posure and nonexposed sites may impose a
great clinical relevance. The sites with no
membrane exposure demonstrated signifi-
cantly greater LF, BIC, and BF, supported
by other experimental and clinical studies
(Nowzari & Slots 1995; Gotfredsen et al.
1993; Lekholm et al. 1993; Becker et al.
1994; Gher et al. 1994; Simion et al. 1994a;
Kohal et al. 1998; Parma-Benfenati et al.
1999). Machtei (2001) recently performed a
meta-analysis and reported that membrane
exposure results in significantly less bone
formation in GBR procedure, and when
compared to GTR procedures, the negative
effects on treatment outcomes were more
detrimental, indicating that primary clo-
sure of healing wound in GBR procedures
is a major factor for the success of new
bone formation in dental implants. How-
ever, only two GBR studies were used for
this analysis. Kohal et al. (1998) demon-
strated that early membrane exposure re-
sulted in significantly less BIC, expressed
as torque required to remove implants,
compared to nonexposed implant sites in a
canine model. Possible reasons for the high
membrane exposure rate in this study in-
cluded a cage-chewing behavior of dogs
(Henry et al. 1997) and remaining flap ten-
sion. Since the membrane exposure, when
present, was observed in entire quadrant,
including control site, the exposure would
have been more likely induced by animal
behavior (or remaining flap tension) rather
than membrane materials.
Histologic observations at 16weeks
demonstrated loss of membrane integrity
even in the sites without membrane ex-
posure, and a pattern of membrane col-
lapse in most of the exposed sites (eight out
of nine) in which less regeneration was ob-
tained. This indicates that the treatment
outcomes were mainly dependent upon
the presence or absence of membrane ex-
posure and/or space collapse, not signifi-
cantly influenced by membrane resorption
time. Owens & Yukna (2001) recently
evaluated the pattern of collagen mem-
brane resorption, comparing three different
collagen membranes, Bio-Gide, AlloDermA
porcine-derived (LifeCell, Branchburg, NJ,
USA), and AlloDermA human-derived (Li-
feCell, Branchburg, NJ, USA), in dogs. They
observed that all membranes had near-com-
plete degradation by 3months and were
completely absent by 4months. Crigger
et al. (1996) reported that highly cross-
linked collagen membranes resulted in sig-
nificantly less attachment gain compared to
weak cross-linked, rapid resorbing collagen
membranes in periodontal defects in dogs.
Several limitations were associated with
the present study. This study is an animal
study which provides a model to the hu-
man situation. Second, the small sample
size in association with large biologic vari-
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ability might have affected the results of
statistical significance. Third, GBR was
employed in surgically created defects
(acute wounds) rather than naturally occur-
ring chronic lesions. The size of the defects
used in the study might not be of and rep-
resent critical-size kinetic defects to
measure the effects of GBR temporally. Fi-
nally, the negative influence of the high
membrane exposure rate and space col-
lapse noted in the present study could have
been reduced by fixating membranes or
adding space-maintaining materials, such
as bone grafts or metal pins. Carpio et al.
(2000) reported that membrane fixation at
GBR surgery resulted in significantly less
postoperative complications with greater
bone regeneration, as compared to no
membrane fixation. In addition, a histo-
logic study in implant dehiscence defects
in monkeys demonstrated that a combined
use of barrier membranes and anorganic
bovine bone substitutes (Bio-Oss) had
greater gains in bone height and width at
6months, compared to other groups, in-
cluding membrane alone, Bio-Oss alone, or
control (Hämmerle et al. 1998). The ration-
ale for the use of bone substitutes in GBR
may include: (1) space creation/mainten-
ance, (2) acting as a scaffold for angiogen-
esis and perivascular cells such as osteopro-
genitor cells, and (3) providing a carrier for
bone growth factors (Hämmerle 1999).
Under the limits of the present study, it
was concluded that GBR treatment using
collagen membranes, either Bio-Gide or Bi-
oMend Extend, may enhance bone re-
generation, including bone height gain,
new bone-to-implant contact, and bone fill,
manifested at a later stage of healing. Space
maintenance and prevention of membrane
exposure during healing could be crucial
factors for the success of GBR.
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Résumé
La régénération osseuse guidée (GBR) provient du princi-
pe de la régénération tissulaire guidée (GTR) et a été utili-
sée pour reconstruire des sites ayant des lésions osseuses
associées aux implants dentaires. Pour la GBR, des mem-
branes collagène dégradables ont été utilisées mais l’infor-
mation scientifique de l’utilisation de membranes colla-
gène pour GBR est limitée. Cette étude a eu pour but
de comparer cliniquement et histomorphométriquement
deux membranes collagène (Bio-GuideA et BioMend Ex-
tendTM) pour le traitement de lésions de déhiscence au
niveau d’implants chez huit chiens bâtards. Les lésions
de déhiscence autour des implants ont été créées chirurgi-
calement dans des rebords édentés à la suite du place-
ment de trois implants endo-osseux bilatéralement au ni-
veau de la mandibule. Chaque lésion de déhiscence im-
plantaire était répartie au hasard dans un des trois
groupes de traitement : 1) contrôle (pas de membrane), 2)
barrière collagène de derme de porc (Bio-GuideA), ou 3)
barrière collagène de tendon bovin (BioMend Extend TM).
Quatre chiens ont été tués après quatre semaines et qua-
tre autres après seize semaines. L’analyse histomorpho-
métrique comprenait le pourcentage de remplissage os-
seux linéaire (LF), de nouveau contact os-implant (BIC) et
l’aire du nouveau remplissage osseux (BF). Les résultats
de l’étude n’ont révélé aucune différence significative par-
mi les groupes pour aucun paramètre après quatre semai-
nes. Cependant après seize semaines, il y avait davantage
de LF, BIC et BF dans les groupes traités par membrane
que dans les contrôles. Les lésions traitées par BioMend
ExtendTM s’accompagnaient davantage de BIC que les
contrôles (p0,05). BIC à seize semaines était significati-
vement plus important qu’à quatre semaines (p0,05).
Neuf des quinze sites examinés avaient la membrane ex-
posée dans la cavitée buccale aboutissant à moins de LF
et BIC que dans les sites sans membrane exposée
(p0,05). Les résultats de cette étude ont montré que 1)
le traitement GBR avec des membranes collagène peut
significativement augmenter la régénération osseuse ap-
rès seize semaines de guérison 2) le maintien de l’espace
et le maintien du recouvrement par la membrane étaient
les deux facteurs les plus importants.
Zusammenfassung
Die gesteuerte Knochenregeneration (GBR) wurde aus
dem Konzept der gesteuerten Geweberegeneration ent-
wickelt und wurde zur Rekonstruktion von Knochende-
fekten im Zusammenhang mit dentalen Implantaten ein-
gesetzt. Für die GBR werden immer häufiger Kollagen-
membranen eingesetzt. Wissenschaftliche Informationen
über die Verwendung von Kollagenmembranen zur GBR
sind nur beschränkt vorhanden. Das Ziel dieser Studie
war es, zwei Kollagenmembranen, Bio-GideA und Bio-
Mend ExtendA, klinisch und histomorphometrisch bei
der Behandlung von Dehiszenzdefekten an 8 nicht rein-
rassigen Hunden zu vergleichen. Die Dehiszenzdefekte
wurden im zahnosen Kiefer chirurgisch geschaffen, dar-
aufhin wurden 3 enossale Implantate beidseits im Unter-
kiefer eingesetzt. Jeder Implantatdehiszenzdefekt wurde
zufällig einer der drei Behandlungsgruppen zugeteilt: (1)
Kontrollgruppe (keine Membran), (2) Kollagenbarriere aus
Schweinehaut (Bio-GideA) oder (3) Kollagenbarriere aus
Rindersehnen (BioMend ExtendA). Die Hunde wurden 4
und 16 Wochen nach der Behandlung geopfert (jeweils 4
Tiere). Die histomorphometrische Analyse bestand aus
folgenden Parametern: % lineare Auffüllung mit Kno-
chen (LF), neuer Implantat-Knochenkontakt (BIC) und
Auffüllung mit neuem Knochen (BF). Die Resultate der
Studie zeigten nach 4 Wochen für keinen der Parameter
signifikante Unterschiede zwischen den Gruppen. Jedoch
konnten nach 16 Wochen mehr LF, BIC und BF für die
membranbehandelten Gruppen als für die Kontrollgruppe
registriert werden. Defekte, welche mit BioMend Ex-
tendA behandelt wurden, zeigten zu diesem Zeitpunkt
signifikant mehr BC als die Kontrollgruppe (p0.05). BIC
nach 16 Wochen war signifikant grösser als BIC nach 4
Wochen (p0.05). Bei 9 von 15 untersuchten Stellen kam
es zu Membranexpositionen, was im Vergleich zu Stellen
ohne Membranexposition zu signifikant weniger LF und
BIC führte (p0.05). Die Resultate dieser Studie zeigen,
dass (1) die GBR-Behandlung mit Kollagenmembranen
die Knochenregeneration signifikant erhöhen kann, was
sich aber erst in einer späten Phase der Heilung (16 Wo-
chen) manifestiert ; und dass (2) die Erhaltung eines Hohl-
raumes und die Bedeckung der Membran die zwei wich-
tigsten Faktoren bei der GBR mit bioresorbierbaren Kolla-
genmembranen darstellen.
Resumen
La regeneración ósea guiada (GBR) evolucionó del concep-
to de regeneración tisular guiada (GTR) y ha sido usada
para reconstruir lugares con deficiencias óseas asociadas
con implantes dentales. Para la GBR, el uso de membra-
nas reabsorbibles de colágeno se ha ido incrementando,
pero en la actualidad, la información cientı́fica sobre el
uso de las membranas de colágeno para GBR es limitada.
Este estudio tuvo la intención de comparar clı́nica e his-
tomorfometricamente dos membranas de colágeno, Bio-
GideA y BioMendExtendTM, para el tratamiento de defec-
tos de dehiscencia en implantes en 8 perros mongrel. Los
defectos de dehiscencia se crearon quirúrgicamente en
crestas edéntulas, seguida de la colocación de 3 implantes
endoóseos bilateralmente en la mandı́bula. Cada defecto
de dehiscencia fue asignado aleatoriamente a uno de los
e grupos de tratamiento: (1) Control (sin membrana) (2)
Barrera de colágeno de dermis porcina (Bio-GideA), o (3)
Barrera de colágeno de tendón bovino (BioMendEx-
tendTM). Los perros se sacrificaron a las 4 y 16 semanas
(4 cada una) tras el tratamiento. El análisis histomorfomé-
trico incluyó % lineal de relleno óseo (LF), contacto nue-
vo hueso a implante (BIC) y área de relleno de nuevo hue-
so (BF). Los resultados del estudio no revelaron diferencias
significativas entre los grupos para ningún parámetro a
las 4 semanas. Sin embargo, a las 16 semanas, se observó
una mayor LF, BIC, y BF en los grupos tratados con mem-
branas que en los controles. Los defectos tratados con Bio-
MendExtendTM demostraron un mayor BIC que el con-
trol (p0.05) en este punto. El BIC a las 16 semanas fue
significativamente mayor que el BIC a las 4 semanas
(p0.05). La exposición de la membrana ocurrió en 9 de
los 15 lugares examinados, resultando en un menor LF y
BIC que los lugares sin exposición de la membrana
(p0.05). Los resultados de este estudio indican que: (1) El
tratamiento de GBR con membranas de colágeno puede
estimular significativamente la regeneración ósea, mani-
festada en estados tardios (16 semanas) de cicatrización;
y (2) El mantenimiento del espacio y la cobertura de la
membrana fueron los dos factores mas importantes que
afectaron la GBR usando membranas de colágeno bio-
rreabsorbibles.
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